Zurück geht es hier Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.
05.05.2025 11:40:00

NNIT A/S: NNIT adjusts 2025 outlook and publishes Q1 figures

The first quarter financial performance was expected to be moderate, but the increased macroeconomic and geopolitical uncertainty has impacted NNIT to a larger extent than expected. Based on the realized results and the continued uncertainty, NNIT adjusts the 2025 financial outlook.

Given the current uncertainty, organic revenue growth is expected to be 0% to 5% (previously 7% to 10%), which is due to postponement of projects and the sales pipeline materializing at a slower pace than planned as customers are hesitating to engage in new contracts, especially within Life Science. Expectations for the Group operating profit margin excluding special items are maintained at 7% to 9% as NNIT is significantly reducing its cost base by adjusting capacity and lowering general spending across regions and on corporate level. Special items are expected to be up to last year’s level of DKK 69m (previously expected to be below the 2024 level) mainly driven by further restructuring costs.

NNIT generated Q1 2025 Group revenue of DKK 464m (Q1 2024: DKK 463m). The organic growth was negative by 0.8% (Q1 2024: 8.0%) due to Region Europe and Region US. Group operating profit excl. special items was DKK 18m (Q1 2024: 24m), equal to a margin of 3.9% (Q1 2024: 5.2%). Profit and margin were mainly impacted by Region Europe and a decrease in Region Denmark driven by overcapacity following the postponement of a large contract, which has been signed in Q2, and the loss of a large public tender. Special items for the Group amounted to DKK 25m (Q1 2024: income DKK 11.3m) primarily driven by restructuring costs.

Financial figures, DKK millionQ1 2025Q1 2024FY 2024
GROUP   
Revenue464463 1,851
Group operating profit excl. special items1824117
Group operating profit margin excl. special items3.9%5.2%6.3%
Special items25-1169
    
REGION EUROPE   
Revenue119126512
Regional operating profit121467
Regional operating profit margin10.0%11.2%13.0%
    
REGION US   
Revenue8793346
Regional operating profit261873
Regional operating profit margin30.4%19.0%21.2%
    
REGION ASIA   
Revenue3732149
Regional operating profit3-28
Regional operating profit margin7.6%-5.3%5.2%
    
REGION DENMARK   
Revenue221212844
Regional operating profit3348151
Regional operating profit margin15.1%22.6%17.9%


Despite the adjustment of expectations for organic growth, NNIT maintains expectations for the Group operating profit margin excl. special items to reach 7% to 9%. NNIT has executed several cost reducing initiatives, which include capacity adjustments across the group, to minimize the impact on profitability.

NNIT will publish the Q1 2025 trading statement on May 5, 2025, one day earlier than planned.

For more information, please contact:

Investor Relations
Carsten Ringius            
EVP & CFO
Tel: +45 3077 8888
carr@nnit.com

Media Relations
Thomas Stensbøl
Press & Communications Manager
Tel: +45 3077 8800
tmts@nnit.com 

ABOUT NNIT

NNIT is a leading provider of IT solutions to life sciences internationally, and to the public and private sectors in Denmark.

We focus on high complexity industries and thrive in environments where regulatory demands and complexity are high.

We advise on and build sustainable digital solutions that work for the patients, citizens, employees, end users or customers.

We strive to build unmatched excellence in the industries we serve, and we use our domain expertise to represent a business first approach – strongly supported by a selection of partner technologies, but always driven by business needs rather than technology.

NNIT consists of group company NNIT A/S and the subsidiary SCALES. Together, these companies employ more than 1,700 people in Europe, Asia and USA.

Attachment


Analysen zu NNIT A-S

  • Alle
  • Kaufen
  • Hold
  • Verkaufen
  • ?
Zu diesem Datensatz liegen uns leider keine Daten vor.
Eintrag hinzufügen

Erfolgreich hinzugefügt!. Zu Portfolio/Watchlist wechseln.

Es ist ein Fehler aufgetreten!

Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben. Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.

CHF
Hinzufügen

3 Knaller-Aktien im BX Musterportfolio📈: Thales, Generali & Swiss Life mit François Bloch

Im BX Morningcall werden folgende Aktien analysiert und erklärt:
📌 Thales Group (FR0000121329)
📌 Assicurazioni Generali (IT0000062072)
📌 Swiss Life Holding (CH0014852781)

➡️ Ausserdem zeigen wir, welche Aktien das Portfolio verlassen haben und warum:
❌ Meta Platforms (US30303M1027)
❌ LPL Financial (US50212V1008)
❌ American Express (US0258161092)

Pünktlich zum Börsenstart diskutieren Investment-Stratege François Bloch und Börsen-Experte David Kunz oder Olivia Hähnel über ausgewählte Top-Aktienwerte aus dem BX Musterportfolio.

👉🏽 https://bxplus.ch/bx-musterportfolio/

3 Knaller-Aktien im BX Musterportfolio📈: Thales, Generali & Swiss Life | Rebalancing im #BXMusterportfolio

Mini-Futures auf SMI

Typ Stop-Loss Hebel Symbol
Short 12’320.74 18.31 B7RS6U
Short 12’560.06 13.42 BKFSAU
Short 12’996.38 8.91 BVKSPU
SMI-Kurs: 12’233.03 05.05.2025 17:30:52
Long 11’640.00 19.68
Long 11’387.51 11.46 B74SQU
Long 10’640.00 7.42
Die Produktdokumentation, d.h. der Prospekt und das Basisinformationsblatt (BIB), sowie Informationen zu Chancen und Risiken, finden Sie unter: https://keyinvest-ch.ubs.com

Aktien in diesem Artikel

NNIT A-S 69.20 -6.36% NNIT A-S

finanzen.net News

Datum Titel
{{ARTIKEL.NEWS.HEAD.DATUM | date : "HH:mm" }}
{{ARTIKEL.NEWS.BODY.TITEL}}